|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| C07K 14/725 | |||
| C07K 16/28 |
| (11) | Patento numeris | 3227323 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15816318.8 |
| Europos patento paraiškos padavimo data | 2015-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/063839 |
| Data | 2015-12-03 |
| (87) | Numeris | WO 2016/090190 |
| Data | 2016-06-09 |
| (30) | Numeris | Data | Šalis |
| 201462087224 P | 2014-12-03 | US |
| (72) |
GILBERT, Mark J., US
|
| (73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY |
| METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY |